Which field uses machine learning and generative AI to analyze large biology datasets to predict a drug's efficacy and safety in compliance with FDA regulations?

• A. AI & drug development
• B. Genomic medicine
• C. Pharmacovigilance
• D. Clinical pharmacology

Answer: (A)

This field applies machine learning and generative AI to analyze large biology datasets to predict a drug's efficacy and safety within FDA regulations. By feeding diverse data from genomics, proteomics, preclinical assays, and early clinical results into predictive models, researchers estimate how well a candidate will work and what risks it may pose. Generative AI can assist in designing new molecules or optimizing properties while adhering to regulatory constraints, helping to streamline decision-making and ensure evidence meets FDA standards for safety and efficacy. While other areas may use AI for related goals, they focus on different stages or aspects of healthcare—genomic medicine centers on tailoring treatments to individuals’ genetics, pharmacovigilance monitors safety after a drug reaches the market, and clinical pharmacology concentrates on how a drug behaves in the body and dosing—without the primary emphasis on AI-driven development and regulatory-compliant prediction of efficacy and safety.